Literature DB >> 12000653

The use of the paediatric tuberculosis score chart in an HIV-endemic area.

Patrick Van Rheenen1.   

Abstract

BACKGROUND: Diagnosing tuberculosis (TB) in a human immunodeficiency virus (HIV)-endemic area is extremely difficult, as the clinical symptoms of HIV-seropositive children can be easily confounded with TB. The paediatric tuberculosis score chart (TSC) was developed for resource-poor countries and its use continues to be promoted despite the fact that this scoring system has not been evaluated in countries with a high HIV prevalence.
OBJECTIVE: To assess the utility of the TSC in an HIV-endemic area.
METHOD: A prospective cohort study conducted between January and December 1999 at St Theresa's Mission Hospital, Copperbelt Province, Zambia. Results of the TSC (TB score) were compared with the results of a diagnostic algorithm, incorporating sputum smear microscopy, culture and polymerase chain reaction of Mycobacterium tuberculosis, tuberculin skin test, chest X-ray and histology eventually.
RESULTS: A total of 147 children were enrolled in the study. On the basis of HIV-serology and clinical findings they were divided into four groups: children with TB (23 HIV-seropositive; 52 HIV-seronegative), 21 HIV-infected children without TB and 51 HIV-seronegative children without TB. The differences in TB scores between the groups were not significant. The sensitivity of the TSC to diagnose TB in this study was 88%; but the specificity was only 25%.
CONCLUSION: The TSC should not be used as a diagnostic tool in countries with a high HIV prevalence. The low specificity of this scoring system leads to overdiagnosis of TB and unnecessary use of costly, antituberculous drugs. New tools for TB diagnosis in children in HIV-endemic areas are urgently needed.

Entities:  

Mesh:

Year:  2002        PMID: 12000653     DOI: 10.1046/j.1365-3156.2002.00882.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  9 in total

1.  Significance of Fas and Fas ligand in tuberculous lymphadenitis.

Authors:  Tehmina Mustafa; Stanley J Mogga; Sayoki G M Mfinanga; Odd Mørkve; Lisbet Sviland
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

Review 2.  The use of diagnostic systems for tuberculosis in children.

Authors:  Stephen M Graham
Journal:  Indian J Pediatr       Date:  2010-12-17       Impact factor: 1.967

3.  Challenges of Childhood TB/HIV Management in Malawi.

Authors:  G Poerksen; Pn Kazembe; Sm Graham
Journal:  Malawi Med J       Date:  2007-12       Impact factor: 0.875

4.  Directly observed treatment for tuberculosis.

Authors:  V K Arora; Rajnish Gupta
Journal:  Indian J Pediatr       Date:  2003-11       Impact factor: 1.967

5.  Xpert® MTB/RIF assay testing on stool for the diagnosis of paediatric pulmonary TB in Tanzania.

Authors:  S Ainan; F F Furia; F Mhimbira; N P Mnyambwa; N Mgina; A Zumla; S G Mfinanga; E Ngadaya
Journal:  Public Health Action       Date:  2021-06-21

6.  QuantiFERON®-TB gold in-tube performance for diagnosing active tuberculosis in children and adults in a high burden setting.

Authors:  Michala V Rose; Godfather Kimaro; Thomas N Nissen; Inge Kroidl; Michael Hoelscher; Ib C Bygbjerg; Sayoki G Mfinanga; Pernille Ravn
Journal:  PLoS One       Date:  2012-07-12       Impact factor: 3.240

7.  La cuerda dulce--a tolerability and acceptability study of a novel approach to specimen collection for diagnosis of paediatric pulmonary tuberculosis.

Authors:  Felicia Chow; Nora Espiritu; Robert H Gilman; Rosmery Gutierrez; Sonia Lopez; A Roderick Escombe; Carlton A W Evans; David A J Moore
Journal:  BMC Infect Dis       Date:  2006-04-04       Impact factor: 3.090

8.  A systematic review of clinical diagnostic systems used in the diagnosis of tuberculosis in children.

Authors:  Emily C Pearce; Jason F Woodward; Winstone M Nyandiko; Rachel C Vreeman; Samuel O Ayaya
Journal:  AIDS Res Treat       Date:  2012-07-17

9.  Effectiveness of the First Dose of BCG against Tuberculosis among HIV-Infected, Predominantly Immunodeficient Children.

Authors:  Joaquim C V D Van-Dunem; Laura C Rodrigues; Luiz Claudio Arraes Alencar; Maria de Fátima Pessoa Militão-Albuquerque; Ricardo Arraes de Alencar Ximenes
Journal:  Biomed Res Int       Date:  2015-06-29       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.